Endometriosis is a chronic inflammatory condition defined by endometrial stroma and glands found outside of the uterine cavity. The most common sites affected are the pelvic peritoneum and ovaries.
May present incidentally in asymptomatic women, or more commonly in women of reproductive age who complain of chronic pelvic pain and/or subfertility.
Clinical suspicion is generally sufficient to initiate therapy, but the diagnosis can only be confirmed by direct visualization and focused biopsies during laparoscopy.
Treatment options include nonsteroidal anti-inflammatories (NSAIDs), combined oral contraceptive pills, progestin-containing compounds, gonadotropin-releasing hormone (GnRH) agonists and antagonists, danazol (or related androgens), and surgical destruction of lesions. Controlled ovarian hyperstimulation and IVF may be considered for women with subfertility.
Individualized care for women with pelvic pain should incorporate a multidisciplinary evaluation and treatment plan that focuses on limiting the risk of recurrence and improving quality of life.
Endometriosis is defined as the presence of endometrial glands and stroma outside the endometrial cavity and uterine musculature. Surgical appearance varies significantly from superficial blebs to infiltrating fibrosis. While direct visualization confirmed by histologic examination remains the gold standard for diagnosis, surgical confirmation of endometriosis is not required before starting therapy.
History and exam
M. Jonathon Solnik, MD, FACOG FACS
Associate Professor of Obstetrics & Gynaecology
Head of Gynaecology & Minimally Invasive Surgery
Faculty of Medicine at the University of Toronto
Mt. Sinai Hospital
MJS is an author of a number of references cited in this topic. He acts as a consultant for AbbVie (manufacturers of depot leuprolide), Medtronic, Hologic, and Olympus, and holds stocks in Felix and Field Trip Inc.
Ari Sanders, MD, FRSCS
Clinical Assistant Professor of Obstetrics and Gynecology
Division of Minimally Invasive Gynecologic Surgery
Department of Obstetrics and Gynecology
Peter Lougheed Centre
University of Calgary
AS declares that he has no competing interests.
Dr M. Jonathon Solnik and Dr Ari Sanders would like to gratefully acknowledge Dr Sharon M. Jakus, a previous contributor to this topic.
SMJ declares that she has no competing interests.
Joseph S. Sanfilippo, MD, MBA
Department of Obstetrics, Gynecology, and Reproductive Sciences
Division of Reproductive Endocrinology and Infertility
University of Pittsburgh
JSS declares that he has no competing interests.
Justin C. Konje, MBBS, FMCOG, MRCOG, FWACS, MD, MBA
Professor of Obstetrics and Gynaecology
Leicester Royal Infirmary
JCK is an author of a reference cited in this topic.
Use of this content is subject to our disclaimer